(Q30399216)
Statements
1 reference
Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age. (English)
1 reference
Adriano Arguedas
1 reference
Carolina Soley
1 reference
Arturo Abdelnour
1 reference
Victor Sales
1 reference
Kelly Lindert
1 reference
Giovanni Della Cioppa
1 reference
Ralf Clemens
1 reference
Costa Rican H1N1 Vaccine Study Group
1 reference
1 January 2011
1 reference
1 reference
58-66
1 reference
Identifiers
1 reference
1 reference